Manuscript citation: Raig ND, Surridge KJ, Sanz-Murillo M, Dederer V, Krämer A, Schwalm MP, Lattal NM, Elson L, Chatterjee D, Mathea S, Hanke T, Leschziner AE, Reck-Peterson SL, Knapp S Type II kinase inhibitors that target Parkinson’s disease–associated LRRK2. Science Advances 11(23). doi: 10.1126/sciadv.adt2050 License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited Protocol status: WorkingWe use this protocol and it's working
Created: September 13, 2024
Last Modified: September 13, 2024
Protocol Integer ID: 107543
Keywords: single molecule, kinesin, purification, microtubule, ASAPCRN, gfp purification protocol from the reck, gfp purification protocol, purification of human k560, gfp motor, human k560, purification, k560, peterson lab
Funders Acknowledgements:ASAP
Grant ID: ASAP-000519